
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES135
One RCT256 with a follow-up of 4.7 years found that treatment with losartan significantly reduced the risk of CV death, stroke, or MI compared to atenolol therapy. RR 0.76 (95% CI 0.58 to 0.98), p=0.031. Level 1++

[@Appel_2003]

